Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Inovio Pharmaceuticals In...

    NASDAQ: INO · Real-Time Price · USD
    2.21
    0.09 (4.25%)
    At close: Jun 06, 2025, 10:16 AM
    4.25%
    Bid 2.2
    Market Cap 81.05M
    Revenue (ttm) 217.76K
    Net Income (ttm) -44.91B
    EPS (ttm) -3.08
    PE Ratio (ttm) -0.72
    Forward PE -1.22
    Analyst Hold
    Ask 2.21
    Volume 139,092
    Avg. Volume (20D) 639,623
    Open 2.15
    Previous Close 2.12
    Day's Range 2.14 - 2.23
    52-Week Range 1.42 - 12.33
    Beta 1.31

    About INO

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol INO
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for INO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 months ago
    -1.7%
    Shares of industrial stocks are trading lower foll... Unlock content with Pro Subscription
    4 months ago
    +18.13%
    Shares of vaccine makers are trading higher after the first bird flu death was reporting in the US. Additionally, a recent CDC report noted an increase in acute respiratory illness activity.
    news image

    3 weeks ago · seekingalpha.com

    Inovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call Transcript

    Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Jennie Willson - IR Jacqui Shea - President & CEO Mike Sumner - Chief Medical O...

    news image

    3 weeks ago · zacks.com

    Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates

    Inovio Pharmaceuticals (INO) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.74. This compares to loss of $1.31 per share a year ago.

    news image

    3 weeks ago · seekingalpha.com

    Inovio Pharmaceuticals, Inc. (INO) Citizens JMP Life Sciences Conference (Transcript)

    Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Citizens JMP Life Sciences Conference May 8, 2025 11:30 AM ET Company Participants Jacqui Shea - President and CEO Mike Sumner - Chief Medical Officer Confer...

    news image

    1 month ago · zacks.com

    Bet on These 5 Top-Ranked Stocks With Rising P/E

    Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Carvana, Context Therapeutics Inc, Inovio Pharmaceuticals, ChargePoint and MSA Safety Inc.

    news image

    1 month ago · zacks.com

    Inovio (INO) Upgraded to Buy: Here's What You Should Know

    Inovio (INO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    news image

    2 months ago · zacks.com

    Down -11.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)

    Inovio (INO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates cou...

    news image

    2 months ago · seekingalpha.com

    Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript

    Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ET Company Participants Jennie Willson - IR Jacqui Shea - President & CEO Mike Sumner - Chief Medical...

    Add to Watchlist